SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies

被引:0
|
作者
Ahmed M. Almehdi
Ghalia Khoder
Aminah S. Alchakee
Azizeh T. Alsayyid
Nadin H. Sarg
Sameh S. M. Soliman
机构
[1] University of Sharjah,College of Sciences
[2] University of Sharjah,College of Pharmacy
[3] University of Sharjah,Research Institute for Medical and Health Sciences
来源
Infection | 2021年 / 49卷
关键词
SARS-CoV-2; Spike protein; Pathogenesis; Mutations; Treatments; Vaccines;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:855 / 876
页数:21
相关论文
共 50 条
  • [1] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
    Almehdi, Ahmed M.
    Khoder, Ghalia
    Alchakee, Aminah S.
    Alsayyid, Azizeh T.
    Sarg, Nadin H.
    Soliman, Sameh S. M.
    INFECTION, 2021, 49 (05) : 855 - 876
  • [2] SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
    McGill, Andrew R.
    Kahlil, Roukiah
    Dutta, Rinku
    Green, Ryan
    Howell, Mark
    Mohapatra, Subhra
    Mohapatra, Shyam S.
    INFECTIOUS DISEASE REPORTS, 2021, 13 (01) : 102 - 125
  • [3] SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
    Salvatori, Giovanni
    Luberto, Laura
    Maffei, Mariano
    Aurisicchio, Luigi
    Roscilli, Giuseppe
    Palombo, Fabio
    Marra, Emanuele
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [4] SARS-CoV-2 variants- Evolution, spike protein, and vaccines
    Chen, Kai-Wei K.
    Huang, Daniel Tsung-Ning
    Huang, Li -Min
    BIOMEDICAL JOURNAL, 2022, 45 (04) : 573 - 579
  • [5] SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
    Giovanni Salvatori
    Laura Luberto
    Mariano Maffei
    Luigi Aurisicchio
    Giuseppe Roscilli
    Fabio Palombo
    Emanuele Marra
    Journal of Translational Medicine, 18
  • [6] Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
    Lim, Heeji
    Kim, Se Eun
    Lee, Yun Ha
    Hwang, Yun-Ho
    Kim, Su Hwan
    Kim, Mi Young
    Chung, Gyung Tae
    Kim, You-Jin
    Kim, Dokeun
    Lee, Jung-Ah
    VIROLOGY, 2022, 573 : 118 - 123
  • [7] Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice
    Sundaram, Appavu K.
    Ewing, Daniel
    Liang, Zhaodong
    Jani, Vihasi
    Cheng, Ying
    Sun, Peifang
    Raviprakash, Kanakatte
    Wu, Shuenn-Jue
    Petrovsky, Nikolai
    Defang, Gabriel
    Williams, Maya
    Porter, Kevin R.
    PATHOGENS, 2021, 10 (05):
  • [8] Vaccines and Therapies in Development for SARS-CoV-2 Infections
    Wu, David
    Koganti, Raghuram
    Lambe, Upendra P.
    Yadavalli, Tejabhiram
    Nandi, Shyam S.
    Shukla, Deepak
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 19
  • [9] Potential antiviral peptides targeting the SARS-CoV-2 spike protein
    Khater, Ibrahim
    Nassar, Aaya
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
  • [10] Potential antiviral peptides targeting the SARS-CoV-2 spike protein
    Ibrahim Khater
    Aaya Nassar
    BMC Pharmacology and Toxicology, 23